Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study

Overview of attention for article published in Cardiovascular Diabetology, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,431 followers.

RT @Miguel_A_Maria: Más evidencias Lo primero a pinchar en DM2 #Glp1 https://t.co/Jljoc3LIZx https://t.co/kxez7v7Tvw

22 Nov 2021

Reply Repost Favourite

RT @Miguel_A_Maria: Más evidencias Lo primero a pinchar en DM2 #Glp1 https://t.co/Jljoc3LIZx https://t.co/kxez7v7Tvw

22 Nov 2021

Reply Repost Favourite

Más evidencias Lo primero a pinchar en DM2 #Glp1 https://t.co/Jljoc3LIZx https://t.co/kxez7v7Tvw

22 Nov 2021

Reply Repost Favourite

【２型DMでのGLP-1-RA vs.基礎インスリン：PSマッチ比較/ CD】イタリア、GLP-1-RA、または基礎インスリン新規開始２型DM、PSマッチ8126例比較：CV疾患合併は15%のみ。２年間の３点MACE HRはGLP-1-RA群で0.59 [0.50-0.71]。 https://t.co/5QWftVa4fq

14 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.